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This paper describes the synthesis, structural characterization, and solution behavior of some xylyl-
linked imidazolium and benzimidazolium cyclophanes decorated with alkyl or alkoxy groups. The 
addition of alkyl/alkoxy chains to the cyclophanes allows for studies in chlorinated solvents, 
whereas previous solution studies of azolium cyclophanes have generally required highly polar 
solvents. The azolium cyclophanes may exist in a syn/syn conformation (azolium rings mutually 
syn, arene rings mutually syn) or a syn/anti conformation (azolium rings mutually syn, arene rings 
mutually anti). The preferred conformation is significantly affected by (i) binding of bromide (ion-
pairing) to the protons on the imidazolium or benzimidazolium rings, which occurs in solutions of 
bromide salts of the cyclophanes in chlorinated solvents, and (ii) the addition of alkoxy groups to 
the benzimidazolium cyclophanes. These structural modifications have also led to cyclophanes that 
adopt conformations not previously identified for similar azolium cyclophane analogues. Detailed 







 Over the past decade azolium cyclophanes have been of significant interest.1 Studies 
involving this class of cyclophanes have focused on challenges associated with synthesis, their 
intriguing conformational behavior, and, in particular, their potential applications in anion 
recognition and, in the case of imidazolium- and benzimidazolium-based cyclophanes, the use of 
them as precursors to N-heterocyclic carbene metal complexes.  
 
Anion binding involving imidazolium cyclophanes is primarily based on hydrogen-bonding of the 
anion with the acidic H2 proton of the imidazolium cation.2-6 Design of specific imidazolium 
cyclophane structures has led to cyclophanes that display improved binding to specific anions, e.g. 






















We have been interested in azolium cyclophanes containing imidazolium or benzimidazolium 
moieties linked by xylyl groups, for example cyclophanes 3-5.7 These types of cyclophanes can 
exhibit fluxional behavior in solution involving the interconversion of different conformers.7,8 In 
some cases, during low-temperature NMR studies, the fluxional behavior can be "frozen-out" and 
the different conformers identified based on their signals in the 1H NMR spectra. In general, 
azolium cyclophanes such as 3-5 exhibit very low solubility in non-polar organic solvents, so the 
VT-NMR studies have been restricted to solutions of the cyclophanes in highly polar solvents such 
as DMSO and methanol.  
 
Our interest in these salts is primarily based on their ability to act as precursors to N-heterocyclic 
carbenes (NHCs) which can form a range of metal complexes. For instance, we and others have 
reported the synthesis and characterization of Pd(II) (e.g. 6), Ni(II), Pt(II), Rh(I), Ir(I), Au(I) (e.g. 
7), and Ag(I) complexes with NHCs derived from azolium cyclophanes.9-16 The properties of these 
complexes are varied and include catalytic behavior of Pd(II) complexes in Heck and Suzuki 
reactions,10,11,15 Au(I) complexes that are luminescent and exhibit potential antimitochondrial 
antitumor behavior,14,17 and Ag(I) complexes that display antimicrobial activity.13,18 Complexes such 
as 6 and 7 tend to exhibit low solubility in organic solvents, paralleling the low solubility of the 
precursor azolium cyclophane 3. We have attempted to improve the solubility of the metal 
complexes in organic solvents by substitution of the cyclophane skeleton with extended alkyl 
chains, and so have explored the synthesis and properties of imidazolium cyclophane salts such as 
8-10.10,12,15 These cyclophanes (8-10) exhibit remarkably different solubilities compared to the 
cyclophanes 3-5, readily dissolving in chlorinated solvents such as chloroform and 
dichloromethane. The cyclophanes also exhibit significantly different solution behavior in 
chlorinated solvents compared to DMSO and methanol, as identified in 1H NMR spectroscopy 
studies. This behavior appears be a consequence of halide interactions with the acidic imidazolium 
H2 protons of the cyclophanes.  
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In this paper we discuss the conformational behavior of cyclophanes bearing extended alkyl chains. 
Our aim here is to understand (i) the conformational behavior of the new alkyl-substituted 
cyclophanes compared to the previously-studied systems; (ii) explore the effect of solvent on 
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 The discussion in this paper is assisted by a brief summary of the solution behavior of the 
previously studied cyclophane salts 3.2Br-5.2Br.7,19 The variable temperature 1H NMR studies were 
performed using DMSO-d6 or CD3OD solutions. The range of solvents was limited because of the 
low solubility of these salts in organic solvents. The room temperature 1H NMR spectra of 3.2Br 
exhibited very broad signals for the benzylic and imidazolium protons, the broad signals indicating 
the probable occurrence of exchange processes. In DMSO-d6 the H2 imidazolium proton is 
observed; however, in CD3OD the imidazolium H2 proton undergoes rapid H/D exchange and is 
not observed.7 At low temperature the exchange processes were sufficiently slow that sharp 1H 
NMR signals were detected for two different conformers, the structures of which were determined 
from the chemical shifts of the signals in the 1H NMR spectrum. In both conformers, the 
imidazolium rings were mutually syn, but the benzene rings were anti in one conformer and syn in 
the other (Scheme 1). Two different dynamic processes were identified: rotation of the imidazolium 
rings about their N-N axis, which interconverted the two different anti conformers, and flip of the 
benzene rings, which interconverted the anti and syn conformers. The imidazolium ring rotation 
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process (anti→anti exchange) was more facile than the benzene ring flip process (anti→syn 
exchange), and rate constants and activation energies for each process were estimated from the 
variable temperature NMR data (See the first entry in Table 1).7 The benzimidazolium cyclophane 
5.2Br displayed behavior similar to that of 3.2Br, including broad signals at room temperature, 



























Scheme 1. Interconversion of the anti and syn conformers of 3. 
 
Table 1. Rate constant and free energy of activation for the exchange processes of the cyclophanes 
3, 5 and 8 
Cyclophane Anion Solvent anti:syna k(anti→antib) ΔG‡(anti→anti) k(anti→synb) ΔG‡(anti→syn) 
3c Br CD3OD 0.78:0.22 740 s-1 @ -13ºC 49 kJ mol-1 120 s-1 @ 27ºC 61 kJ mol-1 
8 Br CD3OD 0.74:0.26 775 s-1 @ -20ºC 48 kJ mol-1 160 s-1 @ 20ºC 59 kJ mol-1 
8 Br CD2Cl2 1:0 104 s-1 @ 5ºC 57 kJ mol-1 d d 
8 PF6 CD3OD 0.81:0.19 677 s-1 @ -20ºC 47 kJ mol-1 107 s-1 @ 20ºC 60 kJ mol-1 
8 PF6 CD2Cl2 0.85:0.15 82 s-1 @ -15ºC 53 kJ mol-1 84 s-1 @ 25ºC 61 kJ mol-1 
        
5e Br DMSO-d6     61 kJ mol-1 
 
a Population ratio at low exchange limit (low temp.); b Processes: anti→anti imidazolium ring rotation; anti→syn arene 
ring flip; c Ref. 7; d Could not be determined. Coalescence not reached; e Ref. 19. 
 
 
 The mesitylene based cyclophane 4.2Br displayed very different solution behavior. For 
solutions of 4.2Br in DMSO-d6, sharp signals (including doublets for the benzylic protons) in the 1H 
NMR spectra at all accessible temperatures indicated the cyclophane to be rigid on the NMR time-
scale.7 The cyclophane adopts an anti/syn conformation, with the imidazolium rings mutually syn 









Figure 1. The anti/syn conformation adopted by 4.2Br in solution and in the solid-state. 
 
 The azolium cyclophane conformations can be determined by analysis of their 1H NMR 
spectral data at slow-exchange limits.1,7,8 The chemical shifts and multiplicities of the signals 
attributed to the benzylic and imidazolium protons are particularly useful. The magnetic anisotropy 
of aromatic rings can significantly influence the chemical shifts of nearby protons. For particular 
conformers the aromatic groups of the cyclophanes are positioned "above" (or "below") the 
imidazolium protons and can exert an electronic influence. The expected chemical shift of the 
imidazolium protons, unaffected by the magnetic anisotropy of nearby aromatic rings, can be based 
on the chemical shifts of the dibenzylimidazolium cation since the phenyl rings of the benzyl 
substituents are not positioned such that their magnetic anisotropies should significantly influence 
the imidazolium protons. The 1H NMR chemical shifts for dibenzylimidazolium chloride, as 
reported in the literature, are H2 δ 10.79 (CDCl3), 10.04 (DMSO-d6), 9.49 (D2O); H4/5 δ 7.34 
(CDCl3), 7.97 (DMSO-d6), 7.70 (D2O).20,21 It should be noted that in CDCl3 the signal for the 
imidazolium H2 proton is considerably downfield (δ 10.79), presumably due to hydrogen-bonding 
to the chloride counter anion. Crabtree and co-workers have reported that the chemical shift of the 
imidazolium H2 proton in N,N'-dibutylimidazolium salts can be indicative of ion-pairing strength—
the stronger the ability of the anion to form hydrogen bonds, the further downfield the H2 signal [δ 









The azolium-linked ortho and ortho/meta imidazolium cyclophanes 8-10, as dibromide salts, were 
prepared by standard procedures involving the reaction of a bis(imidazolylmethyl)arene with a 
bis(bromomethyl)arene. The preparations of these salts are reported elsewhere.7,10,12,15 The 
butoxybenzimidazolium cyclophane salts 11.2Br and 12.2Br were similarly prepared in excellent 
yield (79-84%), by the reaction of the appropriate 1,2-bis(dibutoxybenzimidazolylmethyl)benzene 
with 1,2-bis(bromomethyl)benzene. The precursor dibutoxybenzimidazoles, 4,7-
dibutoxybenzimidazole and 5,6-dibutoxybenzimidazole, were synthesized in three-step sequences 
from 1,4-dibutoxybenzene and 1,2-dibutoxybenzene respectively (Scheme 2). Di-nitration of 1,2-
dibutoxybenzene afforded 1,2-dibutoxy-4,5-dinitrobenzene,23,24 which was reduced with hydrazine 
hydrate and catalytic Pd/C,25 and the resulting diamine treated with formic acid24 to afford 5,6-
dibutoxybenzimidazole. 4,7-Dibutoxybenzimidazole was prepared similarly, but di-nitration of 1,4-
dibutoxybenzene afforded a mixture of isomers, 1,4-dibutoxy-2,3-dinitrobenzene (major) and 1,4-
dibutoxy-2,5-dinitrobenzene (minor) in a ratio of ca. 4:1.26 The mixture was not separated at this 
step. Reduction of the nitro groups was achieved using ammonium formate and catalytic Pd/C in 











































































Scheme 2. Synthesis of 5,6-dibutoxybenzimidazole and 4,7-dibutoxybenzimidazole 
 
 In general, the "non-alkylated" cyclophanes 3.2Br-5.2Br were very soluble in water, 
displayed low solubility in DMSO and methanol, and were insoluble in organic solvents of medium 
polarity such as acetone, chloroform and dichloromethane. The alkylated cyclophanes 8.2Br-12.2Br 
are much more hydrophobic, and exhibit low solubility in water, good solubility in acetone and 
THF, and excellent solubility in DMSO and methanol. Remarkably, they also exhibit excellent 
solubility in chloroform and dichloromethane, displaying higher solubility in these solvents than in 
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acetone and THF. In the cases of 8.2Br-10.2Br, the heptyl-substituted cyclophanes, the general 
trend in solubility is 8.2Br > 9.2Br > 10.2Br. Interestingly, 8.2BPh4 and 8.2PF6, which contain 
counter-anions that are typically used to increase solubility of cations in organic media, have lower 
solubility in organic solvents than 8.2Br. For all the cyclophanes 8.2Br-12.2Br there is evidence of 
ion-pairing between the (benz)imidazolium H2 protons and the bromide ions in chlorinated solvents 
(see below). Such ion-pairing could make the cyclophanes more soluble in the less-polar organic 
solvents. In the case of the PF6- and BPh4- salts ion-pairing would be limited, making the salts more 
ionic in character. 
 
Studies of Conformations in Solutions 
Cyclophanes 8.2Br, 8.2PF6 and 9.2Br 
 The room temperature 1H NMR spectra of solutions of 8.2Br and 9.2Br in DMSO-d6 or 
CD3OD (e.g. Figures 2a and S1-S3) exhibit similar features to 1H NMR spectra for solutions of the 
non-alkylated analogue 3.2Br, e.g., broad signals corresponding to the benzylic and imidazolium 
protons. Low temperature 1H NMR studies of 8.2Br (in CD3OD and CH3OH27) indicated that, upon 
cooling, exchange processes were slowed and at –70 °C two different conformers were identifiable 
from the 1H NMR spectra (Figures 3a and S4-S6), an anti conformer (arene rings mutually anti) and 
a syn conformer (arene rings mutually syn), analogous to the conformers exhibited by 3.2Br. At –70 
°C both anti → syn and anti → anti exchange process appeared "frozen-out". For 8.2Br in CD3OD, 
the ratio of anti to syn conformers in solution at –70 °C was ca. 0.74:0.26, similar to the ratio of ca. 
0.78:0.22 seen for the non-alkylated analogue 3.2Br in CD3OD.7 On warming the solution of 8.2Br 
in CD3OD, the 1H NMR spectra indicated the same behavior that was identified in solutions of 
3.2Br in CD3OD (see Figures S5 and S6).  Initially, a number of the signals attributed to the anti 
conformers began to broaden and eventually coalesced. On further heating, the signals due to the 
syn conformer also broadened, and coalesced with the signals from the anti conformer. These 
results are consistent with the operation of two distinct exchange processes, arene ring flip and 
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imidazolium ring rotation, analogous to those in Scheme 1. Rate constants and activation energies 
for these processes calculated from coalescence temperatures are summarized in Table 1 (see 
Supporting Information for calculations). The results are comparable to those obtained for the 
parent cyclophane, 3.2Br (Table 1).7   
 The above observations suggest that for solutions of 8.2Br and 9.2Br in CD3OD or 
DMSO-d6 the alkylated cyclophanes behave similarly to the non-alkylated analogue 3.2Br, 
displaying the same exchange processes with similar populations of the different conformers. This 
result is perhaps not unexpected, given that the alkyl chains are located on the periphery of the 




Figure 2. 1H NMR spectra (500.1 MHz) of (a) 8.2Br in DMSO-d6, (b) 8.2Br in CD2Cl2, and (c) 
8.2PF6 in CD2Cl2, all recorded at 25 °C. Key: x = residual solvent signals, † = H2O. 
 
 
Figure 3. Downfield region of the 1H NMR spectra (500.1 MHz) of 8.2Br (a) in CD3OD at –70 °C 
and (b) in CD2Cl2 at –40 °C. The region shown in the dashed box is of a spectrum of 8.2Br in 
CH3OH at –70 °C indicating signals for the H2 protons. Key: x = residual solvent signals. 
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 The appearance of the room and low temperature 1H NMR spectra for solutions of 8.2Br 
(and 9.2Br) in chloroform and dichloromethane is in stark contrast to their appearance in DMSO 
and methanol solutions. Detailed NMR studies indicate that the appearance of NMR spectra for 
solutions containing the cyclophane 8 can be interpreted in terms of the interconversion of the 
conformers and the ion-pairing interactions described in Figure 4. The experiments that lead to 































































No bromide binding One bromide binding Two bromides binding
 
Figure 4. The main conformers of 8 and associated bromide binding inferred from 1H NMR 
spectral data: (a) conformations inferred from spectra of solutions of 8.2PF6 in CD2Cl2 or 8.2Br in 
CD3OD (i.e., in the absence of ion-pairing); (b) conformations inferred from spectra of 8.2PF6 in 
CD2Cl2 with one equivalent of Bu4NBr added; and (c) conformations inferred from spectra of 
CD2Cl2 solutions of either 8.2Br, or 8.2PF6 with three equivalents of Bu4NBr added. Chemical shifts 
indicated for imidazolium protons were obtained from spectra of: (a) a solution of 8.2PF6 in CD2Cl2 
at -70 °C, Figure S14; (b) a solution of 8.2PF6 in CD2Cl2 at -40 °C after the addition of one 
equivalent of Bu4NBr, Figure S17; and (c) a solution of 8.2Br in CD2Cl2 at -40 °C, Figure S9.  
 
Identification of the anti/anti conformation of 8 in CD2Cl2 solutions of 8.2Br. 
Whereas solutions of 8.2Br and 9.2Br in DMSO-d6 display broad signals for the benzylic protons 
and all the imidazolium protons, the room temperature 1H NMR spectra of 8.2Br and 9.2Br in 
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CD2Cl2 display very broad signals attributable to the benzylic and imidazolium H4 and H5 protons, 
but a sharp, downfield signal for the imidazolium H2 protons (ca. δ 9.7) (e.g. Figures 2b, S7 and 
S8).  This result suggests that, for solutions of 8.2Br in CD2Cl2, the processes that interconvert the 
predominant conformers in solution do not involve a change to the environment of the imidazolium 
H2 protons.  
 Low temperature 1H NMR spectra of 8.2Br in CD2Cl2 indicated the predominance of only 
one conformer at –40°C (Figures 3b and S9). The signals are sharp, indicating exchange processes 
to be very slow on the NMR time scale. Two sets of AX patterns for the benzylic protons (i.e., four 
doublets in total), one singlet for the imidazolium H2 protons, two signals for the imidazolium H4 
and H5 protons and two singlets for the benzene protons suggested one of only two possible 
conformations (Figure 5), anti/anti (benzene groups mutually anti; imidazolium rings mutually 
anti) or anti/syn (benzene groups mutually anti; imidazolium rings mutually syn). Of particular note 
are the chemical shifts of the imidazolium protons, δ 9.50 (H2) and δ 8.23 and 6.43 (H4 and H5). 
Compared with the chemical shift of the H2 proton of dibenzylimidazolium chloride (H2 δ 10.79, 
H4/5 δ 7.34 in CDCl320), the chemical shift of the imidazolium H2 proton of 8.2Br (δ 9.50 in 
CD2Cl2) is significantly upfield. This upfield shift is consistent with the protons being magnetically 
shielded by an aromatic ring, a phenomenon that would occur in both the anti/anti and anti/syn 
conformers. Likewise, the chemical shifts of the signals for the imidazolium H4 and H5 protons are 
significantly different, suggesting that only one of those protons is magnetically shielded by an 
aromatic ring. The symmetry in cyclophane 8 prevented definitive assignment of which conformer 
was prevalent at low temperatures, but in the similar cyclophane 9, the symmetry is reduced.   
 A low temperature 1H NMR study of 9.2Br in CD2Cl2 (Figure S10) demonstrated that at –40 
°C two similar conformers were present in solution in a ratio of ca. 2.8:1. The 1H NMR data (each 
conformer exhibited one H2 signal near δ 9.5, four doublets for benzylic protons, and one singlet 
and an AA'BB' pattern for the two different benzene rings) are consistent with both conformers 
being anti/syn forms (benzene groups mutually anti; imidazolium rings mutually syn, Figure 6). The 
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identification of which of the two different anti/syn conformers (A or B in Figure 6) was in highest 
concentration at –40 °C could not be determined from the 1H NMR spectra for 9.2Br in CD2Cl2.  
 The structural similarity between 8 and 9 and the similarities in their NMR spectra (cf. 



















Figure 5. Possible low temperature conformers of 8.2Br in CD2Cl2, based on available 1H NMR 
























Figure 6. Possible low temperature conformers of 9.2Br in CD2Cl2. 1H NMR data was consistent 
with the presence of only the anti/syn conformers. 
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Bromide binding to the anti/anti conformation of 8 in CD2Cl2 solutions of 8.2Br. 
 The significance of ion-pairing interactions on the solution behavior of 8 was revealed by a 
1H NMR investigation starting with the bromide-free salt 8.2PF6.  The 1H NMR spectra of 8.2PF6 in 
methanol and in CD2Cl2 were remarkably similar (Figures S11-S14). At low temperatures, both 
displayed signals consistent with the presence of two different conformers in solution: the anti and 
syn conformers identified previously in solutions of 8.2Br in methanol (anti-8 and syn-8 in Figure 
4a). The ratio of the two conformers was ca. 0.81:0.19 (anti:syn) in methanol and ca. 0.85:0.15 
(anti:syn) in CD2Cl2 (cf. 0.75:0.26 anti:syn for 8.2Br in methanol).  
 In the room temperature 1H NMR spectrum of 8.2PF6 in CD2Cl2 (Figure 2c), the H2 protons 
appeared as a very broad signal near δ 7.9, but the corresponding signal for the imidazolium H2 
protons for 8.2Br in CD2Cl2 as room temperature was sharp and much further downfield (ca. δ 9.5, 
Figure 2b). The large change in chemical shift for H2 (Δδ = 1.6 ppm) can be attributed to an 
interaction of a bromide counterion with the imidazolium H2 proton in CD2Cl2 solution, which is 
absent in the more strongly-solvating DMSO-d6 and which has no counterpart in CD2Cl2 solutions 
of 8.2PF6. A CD2Cl2 solution containing 8.2PF6 and ca. three mole equivalents NBu4Br was 
analyzed by 1H NMR spectroscopy over a range of temperatures (Figure S15) and the solution 
behavior of the cyclophane 8 was identical to that of solutions of 8.2Br in CD2Cl2 (Figure S16).  
 The studies described above suggested that the presence of ion-paring between cyclophane 8 
and bromide had a significant influence on the solution behavior of 8.  The stoichiometry of binding 
between the cyclophane and the bromide anions was investigated, initially by the method of 
continuous variations (Job's method; see Supporting Information).28 The change in chemical shift 
for the H2 proton in a sample of 8.2PF6 in CD2Cl2 in response to added bromide was used to 
generate a Job plot (see Supporting Information). Analysis of this plot suggested that a 1:1 
(imidazolium cyclophane 8 : bromide) ion-pair existed in solution. 
 To further explore this 1:1 ion pairing, a solution of 8.2PF6 with one equivalent of NBu4Br 
in CD2Cl2 was examined by variable temperature 1H NMR spectroscopy. The 1H NMR spectrum 
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recorded at –40 °C (Figure S17a) displayed signals consistent with two species—one anti 
conformer and one syn conformer (ca. 0.8:0.2 anti:syn)—the dynamic process that interconverts the 
species being frozen out at this temperature. The NMR signals for both conformers were consistent 
with only the H2 protons being involved in interactions with bromide ions, e.g., anti-8···Br and syn-
8···Br in Figure 4b.  The only significant differences between the chemical shift data for anti-8 and 
anti-8···Br, or syn-8 and syn-8···Br, is the down-field shift of the signal for the imidazolium H2 
protons (Δδ = 1.7 ppm in each case, cf. Figure 4a and 4b). However, despite the Job plot indicating 
a 1:1 binding stoichiometry between 8 and bromide, the 1H NMR spectra of a solution of 8.2PF6 
with one equivalent of NBu4Br in CD2Cl2, i.e. consisting of anti-8···Br and syn-8···Br, were not the 
same as the 1H NMR spectra of solutions of 8.2Br in CD2Cl2. 
  The only significant difference in 1H NMR chemical shifts of anti-8···Br in Figure 4b (from 
a solution of 8.2PF6 in CD2Cl2 after the addition of one equivalent of NBu4Br) and anti-8 in Figure 
4c (the only conformer detected in solutions of 8.2Br in CD2Cl2 at –40 °C) is the downfield shift of 
the signal for one of the imidazolium H4/5 protons (δ ~7.4 → δ 8.23; Δδ = 0.83 ppm). This 
difference is consistent with the imidazolium H4/5 protons interacting with an additional bromide 
ion when more than one equivalent of bromide is present. In solutions of 8 in CD2Cl2 in the 
presence of two or more equivalents of bromide, the only cyclophane species observed in solution 
is an anti conformer ion-pairing with two bromide ions, denoted as anti-8···2Br (Figure 4c). 
Presumably unfavorable steric interactions that would accompany the binding of the second 
bromide ion to protons on the "back" of the imidazolium ring prevents the observation of a syn 
conformer, i.e. syn-8···2Br. 
 In summary, there are two binding events for the cyclophane 8. In the first binding event, 
bromide binds to H2, while in the second binding event, which only occurs after H2 is saturated, 
bromide binds to H4/5. The analysis by Job's method probes the first binding event at room 
temperature. The second binding event involves changes in signals that are too broad at room 
temperature to be analyzed. As a result, the Job's method indicated a 1:1 binding stoichiometry 
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(first binding event) while the subsequent low-temperature investigation indicated an overall 1:2 
stoichiometry (first and second binding events).   
 It is interesting to consider the consequences of the ion-pairing. When ion-pairing involves 
two bromide anions (as for 8.2Br in CD2Cl2), only one conformer of 8 is detectable in solution, the 
interaction of the bromide anions favoring the anti conformer anti-8···2Br, whereas both anti and 
syn conformations are seen when ion pairing involves only one bromide. The kinetics for the 
conformational exchange processes are also significantly influenced by bromide binding. Analysis 
of the variable temperature 1H NMR spectra for 8.2Br in CD2Cl2 (Figures S16) permitted only 
determination of the imidazolium ring rotation process (interconversion of the two anti conformers, 
Figure 7). From coalescence information, we estimate the rate constant for the anti → anti 
exchange process to be 104 ± 4 s-1 at 5 °C, and the free energy of activation for this process to be 57 
± 1 kJ mol-1 (see Supporting Information for calculations). A comparison of the kinetic data is 
presented in Table 1. When the cyclophane 8 is ion-paired with two bromide anions, as for anti-
8···2Br (entry 3, Table 1), the rate constant for the imidazolium ring rotation process is much lower 
and the free energy of activation for this process is much higher—by ca. 10 kJ mol-1—than in the 
absence of any cyclophane-bromide pairing (entries 1, 2 and 4 Table 1). It could be envisaged that, 
with bromide binding to the imidazolium protons, the bromide ions "hold" the imidazolium rings in 
the anti conformation, a higher energy being required to break the imidazolium···bromide 
interaction before imidazolium ring rotation can occur (Figure 7). Similarly, bromide binding slows 
the arene "ring flip" process that interconverts anti and syn conformations of 8. Thus, whereas 
coalescence of benzylic signals for 8 in the absence of bromide (Figures S19-S22) is indicative of 
interconversion of anti and syn conformations, in the presence of bromide (Figure S16), while 
benzylic signals of 8 showed some broadening at high temperature, coalescence did not occur at 
accessible temperatures.  Alcalde et al. have observed a similar "braking" effect for an imidazolium 
linked meta-xylyl cyclophane where the signals for the benzylic protons of the cyclophane appeared 
as a singlet in the presence of chloride or trifluoroacetate but appeared as two pairs of doublets in 
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Figure 7. The predominant conformers in CD2Cl2 solution of 8.2Br and the imidazolium ring 
rotation process that converts the two conformers. 
 
Cyclophane 10.2Br 
 The solution behavior of 10.2Br in DMSO-d6 at room temperature was similar to that of the 
non-alkylated analogue 2.2Br. The 1H NMR spectra suggest that, not unexpectedly, the only 
conformation seen for 10.2Br in DMSO-d6 solution was the anti/syn arrangement (Figure 8). The 
1H NMR spectra (Figure S23) displayed sharp signals including four doublets for the benzylic 
protons and a sharp singlet for the imidazolium H2 protons (at δ 8.47), consistent with anti/syn 
conformer being rigid on the NMR timescale. The upfield chemical shift of the imidazolium H2 
proton signal (δ 8.47, cf. δ 10.04 for dibenzylimidazolium chloride in DMSO-d6) suggests that the 
imidazolium H2 protons are affected by magnetic shielding from a nearby aromatic ring. The 
spectra of 10.2Br in methanol exhibit some interesting differences compared to the spectra of 
DMSO-d6 solutions. The set of doublets corresponding to the benzylic protons of the ortho-xylyl 
group is slightly broadened at room temperature (see Figures S24 and S25), while the doublets for 
the benzylic protons on the mesitylene group are sharp. The signal attributed to the imidazolium H2 
proton (seen in CH3OH solutions, but not seen in CD3OD solutions) is broad at room temperature, 
but sharp at lower temperatures (Figures S26). A number of signals broaden slightly as the 
temperature is lowered to 10 °C and then sharpen as the temperature is lowered further, beyond -10 
°C, but these effects are not accompanied by substantial changes in chemical shifts or changes in 
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the number of signals detected. We do not know the cause of these subtle changes in the variable 
temperature NMR spectra of 10.2Br in methanol. 
 The spectra of 10.2Br in CDCl3 (see Figures S27) exhibit some differences compared to the 
spectra of the DMSO-d6 or methanol solutions. The spectra exhibit sharp signals independent of 
temperature, indicating a structure that is rigid on the NMR timescale. Saturation transfer 1H NMR 
experiments on 10.2Br in CDCl3 at 40 °C showed no evidence of slow exchange processes. The 
chemical shifts of the signals for the imidazolium H4 and H5 protons are significantly different in 
the two solvents (Δδ 1.71 ppm in CDCl3 cf. Δδ 0.2 ppm in DMSO-d6) and those of the imidazolium 
H2 protons are significantly further downfield in CDCl3 (δ 9.84, cf. δ 8.47 in DMSO-d6). These 
data are consistent with an anti/syn conformation for 10 in both CDCl3 and DMSO-d6, but in CDCl3 
with the presence of hydrogen-bonding between the imidazolium protons and bromide ions (Figure 






























Figure 8. Selected 1H NMR chemical shift data for 10.2Br in (a) CDCl3 and (b) DMSO. 
 
Cyclophanes 11.2Br and 12.2Br  
The butoxy-substituted benzimidazolium cyclophanes 11 and 12 display significantly different 
solution behavior compared to their imidazolium analogues 8 and 9 discussed previously. In 
addition, the structural variations between 11 and 12 result in these cations exhibiting significantly 
different solution behaviors to each other, and, in the case of 12, induce a conformation not 
previously identified for imidazolium/benzimidazolium cyclophanes linked by ortho-xylyl groups. 
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 At room temperature solutions of 11.2Br in DMSO-d6 and methanol (Figures S28 and S29) 
exhibited numerous broad signals over the entire 1H NMR spectrum. The signals were consistent 
with multiple conformers undergoing exchange processes. Only in the case of the DMSO solution 
could the temperature be raised sufficiently to achieve coalescence of signals. The high freezing 
point of DMSO meant that the slow exchange limit for spectra of 11 could not be reached, so that 
the nature and relative populations of each of the conformers could not be determined. 1H NMR 
spectra of methanol solutions containing 11.2Br at –10 °C were sharp (Figures S29 and S30) and 
consistent with the presence of two conformers in solution - a syn and an anti conformer (Figure 9) 
in the ratio of ca. 0.75:0.25 respectively. The conformers were identified by the numbers, patterns 
and chemical shifts of the signals in the 1H NMR spectra. Of particular note are the chemical shifts 
(Figure 9) of the benzimidazolium H2 protons (δ 7.41 for the syn conformer and δ 8.61 for the anti) 
and the protons on the fused benzo-ring of the benzimidazolium moiety (δ 7.25 for the syn 




































Figure 9. The two conformers of 11 and selected chemical shifts, from solutions of 11.2Br in 
methanol at –10 °C.  
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 The room temperature 1H NMR spectra for solutions of 11.2Br in CD2Cl2 (Figure S31) 
exhibited sharp signals consistent with only one major conformer in solution (the anti conformer in 
Figure 10). The downfield chemical shift of the benzimidazolium H2 proton (δ 9.87, Figure 10) is 
consistent with the presence of hydrogen-bonding between the proton and a bromide anion. The 
signal is significantly downfield (Δδ 1.3) by comparison with the chemical shift for the equivalent 
proton of the anti conformer in methanolic solutions (δ 8.61, Figure 9). It is interesting to note that 
in methanol the predominant conformer is the syn conformer yet, in the presence of bromide 
binding (in chlorinated solvents), the anti conformer is predominant. It may be that the steric bulk 
of the bromide ion destabilizes the syn conformation, where binding of bromide to H2 would wedge 
the bromide ion between two aromatic rings. 
 Saturation-transfer 1H NMR experiments were conducted to explore the possibility of slow 
exchange processes involving the anti conformer in solutions of 11.2Br in CD2Cl2 at 30 °C (Figure 
S32). Saturation of one of the signals due to aromatic protons on the fused benzo-ring of the 
benizimidazolium moiety (e.g. δ 6.0, Figure 11) resulted in a significant decrease in the intensity of 
the signal attributed to the other proton on the benzo-ring of the benizimidazolium moiety (e.g. δ 
8.0, Figures 11 and S32). Saturation of the signals corresponding to the exo (or endo) benzylic 
protons did not change the intensity of the signals for the corresponding endo (or exo) benzylic 
protons by any appreciable amount. These results suggests that (i) the benzimidazolium rings are 
undergoing partial rotation about their N-N axes, interconverting two anti conformers in a process 
that exchanges the environments of the two aromatic protons on the benzo-fused ring (Figure 11), 
but (ii) arene ring flip processes that would exchange the environments of the benzylic protons are 














Figure 10. The only conformation of 11 (with pertinent 1H chemical shifts) detected in solutions of 

























Figure 11. Benzimidazolium ring rotation (about the N-N axis) that interconverts the two anti 
conformers of 11, as suggested by 1H NMR saturation transfer studies of solutions of 11.2Br at 
room temperature. 
 
 The room temperature 1H NMR spectra of solutions of 12.2Br in DMSO-d6 (Figure 12) 
exhibit sharp signals for the phenyl protons (of the xylyl and benzimidazolium groups) and the 
benzimidazolium-H2 protons, but broadened doublets for the benzylic protons, as well as 
broadened signals corresponding to the methylene protons of the butyl chains. Of particular note is 
the upfield chemical shift of the H2 proton (δ 7.11, Figure 12), which is consistent with magnetic 
shielding of this proton by two aromatic rings. The spectra are consistent with 12 existing in a syn 
conformation. On heating the DMSO-d6 solutions, coalescence of the benzylic signals occurs (at ca. 
70 °C), the signals for the methylene protons of the butyl chain becomes sharp, and all other signals 
remain the same (Figure 12). These results are consistent with the existence of an exchange process 
that interconverts two equivalent syn conformations of 12 (Figure 12). This exchange process 
results in the environments of the benzylic protons to be interchanged and the environments of the 
diastereotopic methylene protons of the butyl chains also being interchanged, while the 
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environments of other protons are unaffected. This exchange presumably occurs via a combination 
of both benzimidazolium ring rotation and benzene ring flip processes, with other conformers as 
(undetected) intermediates. The effective rate constant for the interconversion of the two syn 
conformers is estimated at 719 ± 9 s-1 at 70 °C with an activation energy of 66 ± 2  kJ mol-1. 
 
 
Figure 12. Variable-temperature 1H NMR spectra (500.1 MHz, DMSO-d6) of 12.2Br. Key: x = 
residual solvent signal, † = H2O. See Figure S33 in Supporting Information for additional spectra. 
 
 Interestingly, the 1H NMR spectra of 12.2Br in methanol display sharp signals over a broad 
temperature range consistent with a single "frozen-out" conformation (syn). (The spectrum shown 
in Figure S34 is representative of the spectra over the broad temperature range.) At 50 °C the 
benzylic doublets start to broaden, suggesting the occurrence of very slow exchange processes. The 
signal for the benzimidazolium H2 proton (δ 7.2), observable in CH3OH solutions, is sharp only at 
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low temperature being broadened at high temperatures, presumably due to rapid H-H exchange with 
the methanol hydroxyl proton. The spectral features are suggestive again of only a single syn 
conformer in solution. The 1H NMR spectra of 12.2Br in CDCl3 (Figure S35) are almost identical to 
those in methanol. The signal for the benzimidazolium H2 proton of 12 is still relatively upfield (δ 
7.2), consistent with the H2 protons being magnetically shielded by two benzene rings (i.e., a syn 
conformation for 12) and not being involved in ion pairing interactions with bromide counterions.  
Presumably the butyl substituents in 12 favor the syn conformation of the cyclophane, by sterically 
hindering the approach of the benzene groups to the benzimidazolium groups. In the syn 
conformation, the benzene groups prevent approach of bromide ions to the H2 protons, thereby 
eliminating ion pairing effects at the H2 site. Saturation transfer experiments conducted for a 
solution of 12.2Br in CDCl3 suggest the existence of an exchange process that interconverts two 
equivalent syn conformations (Figure 12), but which was only detectable at temperatures above 
room temperature. 
 The benzimidazolium cyclophanes 11 and 12 are the only ortho-xylyl linked 
imidazolium/benzimidazolium cyclophanes that have exhibited syn conformers where the azolium 
C2—H2 bond point into the cavity between aromatic rings. These two cyclophanes also adopt the 
syn conformation in preference to an anti conformation, whereas for other ortho-xylyl linked 
imidazolium cyclophanes, the anti conformation is dominant. The benzimidazolium cyclophanes 11 
and 12 also display some of the slowest dynamic behavior identified for ortho-xylyl linked 
imidazolium/benzimidazolium cyclophanes. 
 
Solid-state structural studies 
 
Attempts to grow crystals of 8.2Br or 8.2PF6 suitable for crystallographic studies proved 
unsuccessful. It was, however, possible to grow crystals of the tetraphenylborate salt 8.2BPh4, 
although the limited solubility of the salt prevented low temperature 1H NMR studies of solutions of 
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the salt. It is interesting to note that, despite the dominant solution conformer of 8 (regardless of 
counter anion or solvent) being anti/syn (arenes mutually anti and imidazolium rings mutually syn), 
in the solid state crystallographic study of 8.2BPh4, the cyclophane adopts an anti/anti conformation 
(Figure S51). One half of the formula unit comprises the asymmetric unit in a triclinic 
! 
P1  unit cell, 
and an inversion centre lies between the pair of imidazolium rings. Alcalde et al. have reported the 
solid-state structure of an imidazolium-linked meta-xylyl cyclophane (13), which, when crystallized 
as the chloride salt, adopted a anti/anti conformation with one imidazolium H2···chloride hydrogen 










Figure 13. The anti/anti conformer adopted in the solid-state by 13.2 
 
 The present studies of the bromide salts of 11 and 12 are modeled in terms of adducts which 
are quite heavily hydrated, 11.2Br.5H2O and 12.2Br.4H2O, all hydroxylic hydrogen atoms being 
located in difference maps (11.2Br.5H2O) or refinable in (x,y,z,Uiso)H (12.2Br.4H2O).  In 
11.2Br.5H2O (where one formula unit, devoid of crystallographic symmetric, comprises the 
asymmetric unit of the structure), the two imidazole hydrogen atoms contact a bromide ion (H...Br 
2.92 Å (est.)) and a water molecule oxygen atom (H...O 2.32 Å (est.)), a hydrogen-bonded column 
being formed parallel to b (Figure 14). Interestingly, water molecule 2 is 'sandwiched' between the 
phenyl rings (H...centroid distances 2.43, 2.68 Å (est.)) with the centroid-centroid distance being 6.05 
Å (est.) (Figure 15). In 12.2Br.4H2O, where only one imidazole hydrogen atom is 
crystallographically independent (the cation being disposed about a crystallographic 2-axis in 
monoclinic space group C2/c), the contact is to a bromide ion (H...Br 3.08(3) Å). Here, no entity is 
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sandwiched, the inter-centroid distance being 4.94 Å and the phenyl rings obligate parallel (Figure 
S53). The cations pack in columns parallel to c, with a pronounced layering normal to that axis, 
consisting of alternate sheets of cations interspaced by anions and solvent molecules, hydrogen-
bonded (Figure S49 and S50). Full details of hydrogen bonding schemes for 11.2Br.5H2O and 
12.2Br.4H2O are given in the Supporting Information. The crystal packing in 8.2BPh4 is also of 
interest in that the heptyl substituents are disposed parallel to and either side of the ab plane, the 
latter layering the structure (Figure S54).  The anions embrace pairwise about inversion centers (½, 
0, ½).  The phenyl rings of the cation are surrounded by those of the anion in edge-to-face contact. 
 
 









The structure of azolium-linked cyclophanes, the types of counter-anions, and the particular 
solvents in which the cyclophanes are studied, can have a significant influence on the conformers 
observed and the rates of the processes that may interconvert them. The incorporation of alkyl 
chains onto the periphery of the imidazolium-cyclophanes has extended the solubility of the 
cyclophanes to allow studies in chlorinated solvents. With non-coordinating counter-anions the 
solution behaviors of the alkylated cyclophanes in chlorinated solvents were found to be similar to 
that of the cyclophanes with bromide counter-anions in polar solvents such as methanol and 
DMSO. In chlorinated solvents, however, the presence of bromide counter-anions impacts on the 
behavior of the cyclophanes. Thus, in the case of the ortho-linked imidazolium cyclophane 8 only a 
single anti conformer was detected in solution, with the cyclophane forming ion-pairs with two 
bromide anions. Not only did the bromide ions influence the solution conformation but the 
cyclophane···bromide interactions significantly impacted the activation barrier for the processes that 
interconvert the solution conformers, by making rotation of the imidazolium rings about their N-N 
axes more difficult.  
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 In the case of the butoxy-benzimidazolium systems, the position of the butoxy 
fictionalization has a significant influence on the conformations adopted by the cyclophanes. 
Particularly in the case of 12, the preferred conformer is a syn conformer where the 
benzimidazolium-H2 protons are directed into the cavity formed by the two ortho-xylyl groups. 
This is the first time such a conformation has been identified for azolium-linked ortho-cyclophanes, 
and suggests interesting possibilities with respect to the formation of N-heterocyclic carbene metal 
complexes derived from such carbene precursors. We are currently exploring the metal 




General procedures and materials 
 General experimental procedures have been described previously.12,16 The synthesis of the 
cyclophanes salts 8.2Br, 9.2Br and 10.2Br has been reported previously, though an improved 
synthesis of 8.2Br is reported here.7,10,12,15 1,2-Bis(bromomethyl)-1,2-diheptylbenzene and 1,2-
bis(imidazol-1-ylmethyl)-4,5-diheptylbenzene were prepared by the method of Baker et al.12 1,2-
Dibutoxy-4,5-dinitrobenzene23,24 and crude 1,4-dibutoxy-2,3-dinitrobenzene26 (as a mixture 
containing ca. 20 mol% 1,4-dibutoxy-2,5-dinitrobenzene) were prepared by literature procedures. 
Where detailed assignment of 13C NMR spectra is provided below, these assignments have been 
made with the aid of HSQC (1-bond 1H-13C correlation) and HMBC (2/3-bond 1H-13C correlation) 
2D NMR experiments.  
 
Full 1H NMR details for the imidazolium and benzimidazolium cyclophanes are provided in 




1,1',3,3'-Bis(4,5-diheptyl-o-xylyl)diimidazolium dibromide 8.2Br. 
 Solutions of 1,2-bis(imidazol-1-ylmethyl)-4,5-diheptylbenzene (1.0 g, 2.3 mmol) in acetone 
(50 mL) and crude 1,2-bis(bromomethyl)-1,2-diheptylbenzene (1.06 g) in acetone (50 mL) were 
added portionwise, simultaneously, to acetone (180 mL) heated at reflux over the course of 5 h. The 
mixture was then heated at reflux for 4 days. The volume of solvent was concentrated by ca. 120 
mL and then cooled to RT. The resulting precipitate was collected, washed with acetone and dried 
to afford a white powder (1.09 g, 53%). (Found: C, 64.71; H, 9.04; N, 5.95. C50H78N4Br2·2H2O 
requires C, 64.50; H, 8.88; N, 6.02%); δC (CDCl3, 125.8 MHz, 298 K) 14.0 (CH3), 22.6, 29.0, 29.7, 
30.8, 31.7, 32.3 (6 x CH2), 51.7 (br, benzylic CH2), 119.9 (v br), 124.3 (v br), 128.6 (v br), 134.6 
(CH), 135.6 (CH), 145.0 (v br); m/z (ES CH2Cl2) 813.5225 (M-Br) (C50H78N481Br requires 
813.5233).  
 
1,1',3,3'-Bis(4,5-diheptyl-o-xylyl)diimidazolium bis(hexafluorophosphate) 8.2PF6. 
 A solution of 8.2Br (257 mg, 0.29 mmol) in methanol (25 mL) and water (10 mL) was 
added to a solution of potassium hexafluorophosphate (0.7 g, 3.8 mmol) in methanol (25 mL) and 
water (10 mL). The mixture was stirred for 1 h and was then diluted with water (40 mL). The 
resulting precipitate was collected, washed with water (20 mL) and dried to afford a white powder 
(255 mg, 86%). (Found: C, 58.09; H, 7.95; N, 5.14. C50H78N4P2F12·0.1H2O requires C, 58.48; H, 
7.68; N, 5.46%). 
We have previously reported the synthesis of 8.2Br and 8.2BPh4, and the mass and NMR [in 
(CD3)2SO solutions] spectral data of 8.2Br.10 Single crystals of 8.2BPh4 suitable for X-ray 
diffraction studies were grown by slow evaporation of an acetone solution of the cyclophane. 
 
5,6-Dibutoxybenzimidazole (14). 
 Hydrazine hydrate (41 mL, 0.84 mol) was added slowly to a stirred mixture of 1,2-dibutoxy-
4,5-dinitrobenzene (26.5 g, 85 mmol) and palladium on carbon (0.59 g, 10% Pd/C) in ethanol (250 
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mL). After the addition was complete the mixture was heated at reflux for 14 h. The mixture was 
cooled and filtered through celite, under a nitrogen atmosphere. The filtrate was concentrated in 
vacuo to afford a yellow solid (ca. 21 g of crude 1,2-dibutoxy-4,5-diaminobenzene). The solid was 
dissolved in formic acid (100 mL, 90 %) and the resulting solution was heated at reflux fir 3 h. The 
mixture was diluted with aqueous ammonia solution (50 mL, 28%) and then aqueous sodium 
carbonate solution (140 g in 1000 mL). The resulting precipitate was collected, washed with water 
(2 x 100 mL) and air-dried to afford a pale brown solid. The solid was dissolved in toluene (250 
mL) and the mixture was dried by azeotropic distillation of water. The resulting toluene solution 
was concentrated to ca. 150 mL and diluted with hexanes (50 mL). The resulting precipitate was 
collected, washed with hexanes (100 mL) and dried to afford a pale brown powder (18 g, 80%). 
(Found: C, 68.73; H, 8.50; N, 10.49. C15H22N2O2 requires C, 68.67; H, 8.45; N, 10.68%); δH 
[(CD3)2SO, 300.1 MHz] 0.94 (6H, t, 3JH,H 7.4 Hz, 2 x CH3), 1.47 (4H, m, 2 x CH2CH3), 1.71 (4H, m, 
2 x OCH2CH2), 3.95 (4H, t, 3JH,H 6.4 Hz, 2 x OCH2), 7.03 and 7.16 (2H, 2 x br s, 2 x Ar H), 7.98 
(1H, s, NCHN) and 12.1 (1H, s, NH); δC [(CD3)2SO, 75.5 MHz] 13.8 (CH3), 18.8 (CH2), 31.0 (CH2), 
68.7 (OCH2), 96.6 (br, Ar C), 104.1 (br, Ar C), 127.1 (br, Ar C), 136.7 (br, Ar C), 140.3 (NCHN), 
145.6 (br, Ar C) and 146.5 (br, Ar C). 
 
1,2-Bis(5',6'-dibutoxybenzimidazolyl-1'-methyl)benzene (15). 
 Sodium hydride (0.6 g, 15 mmol; 60% dispersion in oil) was added to a solution of 5,6-
dibutoxybenzimidazole (14) (3.36 g, 12.8 mmol) in dry thf (150 mL). The mixture was stirred for 
30 min. To the resulting solution was added a solution of 1,2-bis(bromomethyl)benzene (1.69 g, 6.4 
mmol) in dry thf (30 mL). The mixture was then heated at reflux for 18 h. The mixture was cooled 
and then filtered through a plug of celite and basic alumina. The filtrate was concentrated in vacuo 
and the residue was triturated with hot hexanes (150 mL) to afford a white solid (3.65 g, 91 %). 
(Found: C, 72.72; H, 8.12; N, 8.70. C38H50N4O4 requires C, 72.81; H, 8.04; N, 8.94%); δH (CDCl3, 
300.1 MHz) 0.94 (6H, t, 3JH,H 7.4 Hz, 2 x CH3), 0.97 (6H, t, 3JH,H 7.4 Hz, 2 x CH3), 1.49 (8H, m, 4 x 
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CH2CH3), 1.74 (4H, m, 2 x OCH2CH2), 1.81 (4H, m, 2 x OCH2CH2), 3.80 (4H, t, 3JH,H 6.5 Hz, 2 x 
OCH2), 4.01 (4H, t, 3JH,H 6.5 Hz, 2 x OCH2), 5.17 (4H, s, 2 x benzylic CH2), 6.48 (2H, s, 2 x 
benzimidazole Ar CH), 7.03-7.10 (2H, AA' part of AA'XX' pattern, xylyl Ar 3-CH and 6-CH), 7.27 
(2H, s, 2 x benzimidazole Ar CH), 7.30-7.37 (2H, XX' part of AA'XX' pattern, xylyl Ar 4-CH and 
5-CH) and 7.64 (2H, s, 2 x NCHN); δC (CDCl3, 75.5 MHz) 13.8 (CH3), 19.18 (CH2CH3), 19.23 
(CH2CH3), 31.22 (CH2), 31.24 (CH2), 46.4 (benzylic CH2), 69.3 (OCH2), 69.5 (OCH2), 94.7 
(benzimidazole CH), 104.3 (benzimidazole CH), 127.6 (benzimidazole C), 129.16 (xylyl Ar CH 
C3/6), 129.22 (xylyl Ar CH C4/5), 133.1 (xylyl Ar C C1/2), 137.1 (benzimidazole C), 141.0 
(NCHN), 147.1 (benzimidazole C-O) and 147.8 (benzimidazole C-O). 
 
1,1',3,3'-Bis(o-xylyl)bis(5',6'-dibutoxybenzimidazolium) dibromide 11.2Br. 
 Solutions of 1,2-bis(5',6'-dibutoxybenzimidazolylmethyl)benzene (15) (1.67 g, 2.7 mmol) in 
acetone (50 mL) and 1,2-bis(bromomethyl)benzene (0.716 g, 2.7 mmol) in acetone (50 mL) were 
added portionwise, simultaneously, to acetone (200 mL) heated at reflux over the course of 7 h. The 
mixture was then heated at reflux overnight. The volume of solvent was concentrated by ca. 100 
mL and then cooled to RT. The resulting precipitate was collected, washed with acetone and dried 
to afford a white powder (1.9 g, 79%), which can be recrystallized from methanol/water solutions. 
(Found: C, 59.43; H, 6.51; N, 5.77. C46H58N4O4Br2.2H2O requires C, 59.61; H, 6.74; N, 6.05%); δC 
(CDCl3, 75.5 MHz) 13.8 and 14.0 (CH3), 19.1 and 19.3 (CH2CH3), 30.8 and 31.0 (CH2), 50.7 and 
52.0 (benzylic CH2), 69.6 and 70.4 (OCH2), 96.3 and 97.4 (benzimidazolium CH), 123.8 and 125.9 
(benzimidazolium C), 132.3 and 134.8 (xylyl Ar CH C3/6), 130.7 and 134.3 (xylyl Ar CH C4/5), 






4,7-Dibutoxybenzimidazole (16).  
 Palladium on carbon (10%, 0.4 g) was added to a mixture of crude 1,4-dibutoxy-2,3-
dinitrobenzene (6.6 g of mixture, ca. 17 mmol of 1,4-dibutoxy-2,3-dinitrobenzene) and ammonium 
formate (24 g, 0.38 mol) in water (40 mL) and ethanol (180 mL). The mixture was heated at ca. 60 
°C, for 1.25 h with stirring, under a nitrogen atmosphere. The mixture was allowed to cool and was 
then filtered through celite, under nitrogen. The filtrate was concentrated in vacuo. The residue was 
treated with formic acid (90%, 66 mL) and the resulting mixture was heated at reflux for 2 h. The 
mixture was then allowed to cool overnight and was then filtered (by-products 
crystallize/precipitate with slow cooling). The filter cake was washed with formic acid (90%, 20 
mL). The formic acid solutions were combined and then treated with aqueous ammonia (28%, 200 
mL). The resulting solid was collected and recrystallized from ethyl acetate (including treatment 
with activated carbon) to afford off-white crystals (2.5 g, 56%) (Found: C, 68.43; H, 8.17; N, 10.56. 
C15H22N2O2 requires C, 68.67; H, 8.45; N, 10.68%); δH [(CD3)2SO, 300.1 MHz] 0.94 (6H, t, 3JH,H 7.4 
Hz, 2 x CH3), 1.48 (4H, m, 2 x CH2CH3), 1.73 (4H, m, 2 x OCH2CH2), 4.05 (2H, t, 3JH,H 6 Hz, 
OCH2), 4.12 (2H, t, 3JH,H 6 Hz, OCH2), 6.51 (1H, d,3JH,H 8 Hz, Ar H), 6.59 (1H, d,3JH,H 8 Hz, Ar H), 
8.00 (1H, s, NCHN) and 12.62 (1H, s, NH); δC [(CD3)2SO, 75.5 MHz] 13.8 (CH3), 18.76, 18.81 (2 x 
CH2), 31.0, 31.1 (2 x CH2), 67.8, 68.2 (2 x OCH2), 103.9 (2 x Ar CH), 125.1 (Ar C), 135.0 (Ar C), 
139.98 (Ar C), 140.01 (NCHN) and 144.7 (Ar C). 
 
1,2-Bis(4',7'-dibutoxybenzimidazolyl-1'-methyl)benzene (17). 
 Sodium hydride (0.52 g, 13 mmol; 60% dispersion in oil) was added to a mixture of 4,7-
dibutoxybenzimidazole (16) (2.49 g, 9.5 mmol) in dry thf (120 mL). The mixture was stirred for 40 
min. To the resulting solution was added a solution of 1,2-bis(bromomethyl)benzene (1.39 g, 5.25 
mmol) in dry thf (45 mL). The mixture was then heated at reflux overnight. The mixture was cooled 
and then filtered through a plug of celite. The filtrate was concentrated in vacuo and the residue was 
dissolved in ethyl acetate (150 mL) and the solution was filtered through a plug of silica. The 
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filtrate was concentrated in vacuo and the residue was triturated with hot hexanes (175 mL). The 
mixture was cooled, the solution was decanted and the solid was triturated again with hot fresh 
hexanes (50 mL). After cooling the solid was collected and recrystallized by dissolving the solid in 
dichloromethane (5 mL) and layering the solution with hexanes (100 mL), which afforded off-white 
crystals (2.12 g, 71%). (Found: C, 72.65; H, 7.90; N, 8.74. C38H50N4O4 requires C, 72.81; H, 8.04; 
N, 8.94%); δH [(CD3)2SO, 500.1 MHz] 0.74 (6H, t, 3JH,H 7.4 Hz, 2 x CH3), 0.95 (6H, t, 3JH,H 7.4 Hz, 
2 x CH3), 1.08-1.16 (4H, m, 2 x CH2CH3), 1.41-1.52 (8H, 2 x m, 2 x OCH2CH2 and 2 x CH2CH3), 
1.71-1.76 (4H, m, 2 x OCH2CH2), 3.88 (4H, t, 3JH,H 6.5 Hz, 2 x OCH2), 4.12 (4H, t, 3JH,H 6.5 Hz, 2 x 
OCH2), 5.75 (4H, s, 2 x benzylic CH2), 6.58 (2H, d, 3JH,H 8.6 Hz, 2 x benzimidazole Ar 7'-CH), 6.63 
(2H, d, 3JH,H 8.6 Hz, 2 x benzimidazole Ar 6'-CH), 6.67-6.71 (2H, AA' part of AA'XX' pattern, xylyl 
Ar 3-CH and 6-CH), 7.16-7.20 (2H, XX' part of AA'XX' pattern, xylyl Ar 4-CH and 5-CH) and 
7.95 (2H, s, 2 x NCHN); δC [(CD3)2SO, 125.8 MHz] 13.6 (CH3), 13.8 (CH3), 18.5 (CH2CH3), 18.8 
(CH2CH3), 30.5 (OCH2CH2), 31.1 (OCH2CH2), 46.5 (benzylic CH2), 67.9 (OCH2), 68.2 (OCH2), 
104.3 (benzimidazole 5'-CH), 104.4 (benzimidazole 6'-CH), 124.9 (benzimidazole 8'-C), 126.4 
(xylyl Ar 3-CH and 6-CH), 127.7 (xylyl Ar 4-CH and 5-CH), 135.1 (xylyl Ar 1-C and 2-C), 135.7 
(benzimidazole 9'-C), 140.6 (benzimidazole B-CO), 143.0 (NCHN) and 144.8 (benzimidazole A-
CO). 
 
1,1',3,3'-Bis(o-xylyl)bis(4',7'-dibutoxybenzimidazolium) dibromide 12.2Br. 
 Solutions of 1,2-bis(4',7'-dibutoxybenzimidazolylmethyl)benzene (17) (1.44 g, 2.3 mmol) in 
acetone (60 mL) and 1,2-bis(bromomethyl)benzene (0.67 g, 2.5 mmol) in acetonitrile (60 mL) were 
added portionwise, simultaneously, to acetonitrile (500 mL) heated at reflux over the course of 6.5 
h. The mixture was then heated at reflux overnight. The mixture was concentrated in vacuo. The 
residue was recrystallized by dissolving the solid in chloroform (8 mL) and layering the solution 
with ethyl acetate (110 mL), which afforded colorless crystals (1.72 g, 84%). (Found: C, 58.65; H, 
6.63; N, 5.66. C46H58N4O4Br2.3H2O requires C, 58.48; H, 6.83; N, 5.93%); δC (CDCl3, 125.8 MHz) 
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13.9 (CH3), 19.3 (CH2CH3), 31.3 (OCH2CH2), 51.2 (benzylic CH2), 70.1 (OCH2), 109.0 
(benzimidazolium 5'-CH and 6'-CH), 121.8 (benzimidazolium C), 131.4 (xylyl 1-C and 2-C), 131.9 




Full spheres of 'low'-temperature CCD area-detector diffractometer data were measured (Bruker 
AXS instrument, ω-scans; monochromatic Mo Kα radiation; λ = 0.71073 Å), yielding Nt(otal) 
reflections, these merging to N unique (Rint cited) after 'empirical'/multiscan absorption correction 
(proprietary software), No with F > 4σ(F) being considered 'observed' and used in the full matrix 
least squares refinements on F2; anisotropic displacement parameter forms were refined for the non-
hydrogen atoms, hydrogen atom treatment following a 'riding' model.  Neutral atom complex 
scattering factors were employed within the Xtal 3.7 and SHELXL 97 programs;29 individual 
variations in procedure are noted as 'variata'.  Pertinent results are given below and in the text and 
Figures and the Supporting Information; full .cif depositions (excluding structure factor amplitudes) 
are deposited with the Cambridge Crystallographic Data Centre, CCDC 653544-653546.   
 
 
8. 2BPh4 ≡ C98H118B2N4, Mr = 1373.7. Triclinic, space group 
! 
P1 , a = 10.212(2), b = 10.986(2), c = 
19.149(3) Å, α = 73.713(2), β = 80.078(3), γ = 78.970(3)°, V = 2008 Å3. Dc (Z = 1) = 1.136 g cm-3. 
µMo = 0.06 mm-1; specimen: 0.65 x 0.08 x 0.02 mm; 'T'min/max = 0.84. 2θmax = 58°; Nt = 20164, N = 
9877 (Rint = 0.039), No = 5532; R = 0.049, Rw = 0.040.  T ca. 153 K. 
Variata.  All hydrogen atoms were refined in (x,y,z,Uiso)H (refinement on |F|).   
 
11. 2Br.5H2O ≡ C46H68Br2N4O7, Mr = 980.9. Triclinic, space group 
! 
P1 , a = 9.051(2), b = 
10.069(2), c = 27.751(5) Å, α = 80.531(3), β = 80.729(3), γ = 80.473(3)°, V = 2437 Å3. Dc (Z = 2) = 
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1.337 g cm-3. µMo = 1.7 mm-1; specimen: 0.68 x 0.08 x 0.06 mm; 'T'min/max = 0.88.  2θmax = 50°; Nt = 
23127, N = 8540 (Rint = 0.087), No = 6244; R = 0.056, Rw = 0.12.  T ca. 153 K. 
 
12. 2Br.4H2O ≡ C46H66Br2N4O8, Mr = 962.9. Monoclinic, space group C2/c, a = 20.524(2), b = 
20.512(2), c = 13.607(1) Å, β = 126.334(1)°, V = 4615 Å3. Dc (Z = 4) = 1.386 g cm-3. µMo = 1.8 mm-
1; specimen: 0.55 x 0.38 x 0.24 mm; 'T'min/max = 0.74.  2θmax = 66°; Nt = 31846, N = 8619 (Rint = 
0.023), No = 6926; R = 0.034, Rw = 0.063.  T ca. 170 K. 
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cyclophane salts 8.2Br, 8.2PF6, 9.2Br, 10.2Br, 11.2Br and 12.2Br in various solvents including 
DMSO-d6, CD3OD, CH3OH, CD2Cl2, and CDCl3; Job plot information for 8; details about the 
estimation of rate constants and activation energies for dynamic NMR experiments; 13C NMR 
spectra for 8.2Br, 11.2Br and 12.2Br; 1H and 13C NMR spectra for 14, 15, 16 and 17; tables 
detailing the hydrogen bonding in the solid-state structures of 11.2Br and 12.2Br; figures of the unit 
cells and hydrogen-bonding for 11.2Br.5H2O and 12.2Br.4H2O; and figures containing atom labels 
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